|
1: [No authors listed]
Niacin aids cholesterol control. But choose "extended release"
to minimize
"flushing" risk.
Heart Advis. 2003 Jul;6(7):3.
PMID: 12921040
2: Morgan JM, Capuzzi DM, Baksh RI, Intenzo C, Carey CM, Reese D, Walker
K.
Effects of extended-release niacin on lipoprotein subclass distribution.
Am J Cardiol. 2003 Jun 15;91(12):1432-6.
PMID: 12804729
3: Capuzzi DM, Morgan JM, Weiss RJ, Chitra RR, Hutchinson HG, Cressman
MD.
Beneficial effects of rosuvastatin alone and in combination with
extended-release niacin in patients with a combined hyperlipidemia and
low
high-density lipoprotein cholesterol levels.
Am J Cardiol. 2003 Jun 1;91(11):1304-10.
PMID: 12767421
4: Velling DA, Dodick DW, Muir JJ.
Sustained-release niacin for prevention of migraine headache.
Mayo Clin Proc. 2003 Jun;78(6):770-1.
PMID: 12934790
5: Miller M.
Niacin as a component of combination therapy for dyslipidemia.
Mayo Clin Proc. 2003 Jun;78(6):735-42. Review.
PMID: 12934785
6: McKenney J.
Niacin for dyslipidemia: considerations in product selection.
Am J Health Syst Pharm. 2003 May 15;60(10):995-1005.
PMID: 12789870
7: Bays HE, Dujovne CA, McGovern ME, White TE, Kashyap ML, Hutcheson
AG, Crouse JR; ADvicor Versus Other Cholesterol-Modulating Agents Trial
Evaluation.
Comparison of once-daily, niacin extended-release/lovastatin with standard
doses of atorvastatin and simvastatin (the ADvicor Versus Other
Cholesterol-Modulating Agents Trial Evaluation [ADVOCATE]).
Am J Cardiol. 2003 Mar 15;91(6):667-72.
PMID: 12633795
8: Hunninghake DB, McGovern ME, Koren M, Brazg R, Murdock D, Weiss S,
Pearson T.
A dose-ranging study of a new, once-daily, dual-component drug product
containing niacin extended-release and lovastatin.
Clin Cardiol. 2003 Mar;26(3):112-8.
PMID: 12685616
9: Kastelein J.
What future for combination therapies?
Int J Clin Pract Suppl. 2003 Mar;(134):45-50. Review.
PMID: 12793597
10: Yim BT, Chong PH.
Niacin-ER and lovastatin treatment of hypercholesterolemia and mixed dyslipidemia.
Ann Pharmacother. 2003 Jan;37(1):106-15. Review.
PMID: 12503944
11: Moon YS, Kashyap ML.
Niacin extended-release/lovastatin: combination therapy for lipid disorders.
Expert Opin Pharmacother. 2002 Dec;3(12):1763-71. Review.
PMID: 12472373
12: Duvall WL, Blazing MA, Saxena S, Guyton JR.
Targeting cardiovascular risk associated with both low density and high
density
lipoproteins using statin-niacin combination therapy.
J Cardiovasc Risk. 2002 Dec;9(6):339-47.
PMID: 12478203
13: [No authors listed]
Niacin seems OK for people with diabetes.
Health News. 2002 Oct;8(10):7-8.
PMID: 12416488
14: Ito MK.
Niacin-based therapy for dyslipidemia: past evidence and future advances.
Am J Manag Care. 2002 Sep;8(12 Suppl):S315-22. Review.
PMID: 12240703
15: Pieper JA.
Understanding niacin formulations.
Am J Manag Care. 2002 Sep;8(12 Suppl):S308-14. Review.
PMID: 12240702
16: Pan J, Van JT, Chan E, Kesala RL, Lin M, Charles MA.
Extended-release niacin treatment of the atherogenic lipid profile and
lipoprotein(a) in diabetes.
Metabolism. 2002 Sep;51(9):1120-7.
PMID: 12200755
17: Grundy SM, Vega GL, McGovern ME, Tulloch BR, Kendall DM, Fitz-Patrick
D,
Ganda OP, Rosenson RS, Buse JB, Robertson DD, Sheehan JP; Diabetes Multicenter
Research Group.
Efficacy, safety, and tolerability of once-daily niacin for the treatment
of dyslipidemia associated with type 2 diabetes: results of the assessment
of diabetes control and evaluation of the efficacy of niaspan trial.
Arch Intern Med. 2002 Jul 22;162(14):1568-76.
PMID: 12123399
18: Kuvin JT, Ramet ME, Patel AR, Pandian NG, Mendelsohn ME, Karas RH.
A novel mechanism for the beneficial vascular effects of high-density
lipoprotein cholesterol: enhanced vasorelaxation and increased endothelial
nitric oxide synthase expression.
Am Heart J. 2002 Jul;144(1):165-72.
PMID: 12094204
19: Pan J, Lin M, Kesala RL, Van J, Charles MA.
Niacin treatment of the atherogenic lipid profile and Lp(a) in diabetes.
Diabetes Obes Metab. 2002 Jul;4(4):255-61.
PMID: 12099974
20: Kashyap ML, McGovern ME, Berra K, Guyton JR, Kwiterovich PO, Harper
WL,
Toth PD, Favrot LK, Kerzner B, Nash SD, Bays HE, Simmons PD.
Long-term safety and efficacy of a once-daily niacin/lovastatin formulation
for patients with dyslipidemia.
Am J Cardiol. 2002 Mar 15;89(6):672-8.
PMID: 11897208
21: Stein EA.
Managing dyslipidemia in the high-risk patient.
Am J Cardiol. 2002 Mar 7;89(5A):50C-57C. Review.
PMID: 11900720
22: Wink J, Giacoppe G, King J.
Effect of very-low-dose niacin on high-density lipoprotein in patients
undergoing long-term statin therapy.
Am Heart J. 2002 Mar;143(3):514-8.
PMID: 11868059
23: Gupta EK, Ito MK.
Lovastatin and extended-release niacin combination product: the first
drug combination for the management of hyperlipidemia.
Heart Dis. 2002 Mar-Apr;4(2):124-37. Review.
PMID: 11975844
24: Taher TH, Dzavik V, Reteff EM, Pearson GJ, Woloschuk BL, Francis
GA.
Tolerability of statin-fibrate and statin-niacin combination therapy in
dyslipidemic patients at high risk for cardiovascular events.
Am J Cardiol. 2002 Feb 15;89(4):390-4.
PMID: 11835917
25: SoRelle R.
Niacin-simvastatin combination benefits patients with coronary artery
disease.
Circulation. 2001 Dec 11;104(24):E9050-60.
PMID: 11764785
26: Kane MP, Hamilton RA, Addesse E, Busch RS, Bakst G.
Cholesterol and glycemic effects of Niaspan in patients with type 2 diabetes.
Pharmacotherapy. 2001 Dec;21(12):1473-8.
PMID: 11765300
27: Brown BG, Zhao XQ, Chait A, Fisher LD, Cheung MC, Morse JS, Dowdy
AA,
Marino EK, Bolson EL, Alaupovic P, Frohlich J, Albers JJ.
Simvastatin and niacin, antioxidant vitamins, or the combination for the
prevention of coronary disease.
N Engl J Med. 2001 Nov 29;345(22):1583-92. Summary for patients in: Curr
Cardiol
Rep. 2002 Nov;4(6):486.
PMID: 11757504
28: Jacobson TA.
Combination lipid-altering therapy: an emerging treatment paradigm for
the 21st century.
Curr Atheroscler Rep. 2001 Sep;3(5):373-82. Review.
PMID: 11487448
29: McKenney JM, McCormick LS, Schaefer EJ, Black DM, Watkins ML.
Effect of niacin and atorvastatin on lipoprotein subclasses in patients
with
atherogenic dyslipidemia.
Am J Cardiol. 2001 Aug 1;88(3):270-4.
PMID: 11472706
30: Wolfe ML, Vartanian SF, Ross JL, Bansavich LL, Mohler ER 3rd, Meagher
E,
Friedrich CA, Rader DJ.
Safety and effectiveness of Niaspan when added sequentially to a statin
for
treatment of dyslipidemia.
Am J Cardiol. 2001 Feb 15;87(4):476-9, A7.
PMID: 11179541
31: Tavintharan S, Kashyap ML.
The benefits of niacin in atherosclerosis.
Curr Atheroscler Rep. 2001 Jan;3(1):74-82. Review.
PMID: 11123852
32: Gedye A.
Hypothesized treatment for migraines using low doses of tryptophan, niacin,
calcium, caffeine, and acetylsalicylic acid.
Med Hypotheses. 2001 Jan;56(1):91-4.
PMID: 11133261
33: Robinson AW, Sloan HL, Arnold G.
Use of niacin in the prevention and management of hyperlipidemia.
Prog Cardiovasc Nurs. 2001 Winter;16(1):14-20. Review.
PMID: 11252872
34: Sprecher DL.
Raising high-density lipoprotein cholesterol with niacin and fibrates:
a
comparative review.
Am J Cardiol. 2000 Dec 21;86(12A):46L-50L. Review.
PMID: 11374856
35: Knopp RH.
Evaluating niacin in its various forms.
Am J Cardiol. 2000 Dec 21;86(12A):51L-56L.
PMID: 11374857
36: Pearson TA.
Divergent approaches to the treatment of dyslipidemia with low levels
of
high-density lipoprotein cholesterol.
Am J Cardiol. 2000 Dec 21;86(12A):57L-61L. Review.
PMID: 11374858
37: Arntz HR, Agrawal R, Wunderlich W, Schnitzer L, Stern R, Fischer
F,
Schultheiss HP.
Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated
immediately after a coronary event (the randomized Lipid-Coronary Artery
Disease
[L-CAD] Study).
Am J Cardiol. 2000 Dec 15;86(12):1293-8.
PMID: 11113401
38: Garg R, Elam MB, Crouse JR 3rd, Davis KB, Kennedy JW, Egan D, Herd
JA,
Hunninghake DB, Johnson WC, Kostis JB, Sheps DS, Applegate WB.
Effective and safe modification of multiple atherosclerotic risk factors
in
patients with peripheral arterial disease.
Am Heart J. 2000 Nov;140(5):792-803.
PMID: 11054628
39: Chesney CM, Elam MB, Herd JA, Davis KB, Garg R, Hunninghake D, Kennedy
JW,
Applegate WB.
Effect of niacin, warfarin, and antioxidant therapy on coagulation parameters
in patients with peripheral arterial disease in the Arterial Disease Multiple
Intervention Trial (ADMIT).
Am Heart J. 2000 Oct;140(4):631-6.
PMID: 11011338
40: Elam MB, Hunninghake DB, Davis KB, Garg R, Johnson C, Egan D, Kostis
JB,
Sheps DS, Brinton EA.
Effect of niacin on lipid and lipoprotein levels and glycemic control
in
patients with diabetes and peripheral arterial disease: the ADMIT study:
A
randomized trial. Arterial Disease Multiple Intervention Trial.
JAMA. 2000 Sep 13;284(10):1263-70.
PMID: 10979113
41: Mack WJ, Xiang M, Shircore AM, Selzer RH, Hodis HN, Azen SP.
Efficacy of two lipid-lowering treatments on quantitative coronary angiographic
endpoints.
Cardiovasc Drugs Ther. 2000 Aug;14(4):411-8.
PMID: 10999648
42: Lomnicky Y, Haimov T, Luria MH, Friedman M, Hoffman A.
Pharmacodynamic effects of bezafibrate and niacin combination: implications
of
the mode of administration.
J Pharm Sci. 2000 Aug;89(8):1046-53.
PMID: 10906728
43: Morato Hernandez ML, Ichazo Cerro MS, Alvarado Vega AG, Zamora Gonzalez
J,
Cardoso Saldana GC, Posadas Romero C.
[Efficacy and safety of immediate-release niacin in patients with ischemic
cardiopathy. Experience of the Instituto Nacional de Cardiologia "Ignacio
Chavez"]
Arch Inst Cardiol Mex. 2000 Jul-Aug;70(4):367-76. Spanish.
PMID: 11075282
44: Goldberg A, Alagona P Jr, Capuzzi DM, Guyton J, Morgan JM, Rodgers
J,
Sachson R, Samuel P.
Multiple-dose efficacy and safety of an extended-release form of niacin
in the
management of hyperlipidemia.
Am J Cardiol. 2000 May 1;85(9):1100-5.
PMID: 10781759
45: Guyton JR, Blazing MA, Hagar J, Kashyap ML, Knopp RH, McKenney JM,
Nash DT, Nash SD.
Extended-release niacin vs gemfibrozil for the treatment of low levels
of
high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group.
Arch Intern Med. 2000 Apr 24;160(8):1177-84.
PMID: 10789612
46: Zema MJ.
Gemfibrozil, nicotinic acid and combination therapy in patients with isolated
hypoalphalipoproteinemia: a randomized, open-label, crossover study.
J Am Coll Cardiol. 2000 Mar 1;35(3):640-6.
PMID: 10716466
47: Capuzzi DM, Morgan JM, Brusco OA Jr, Intenzo CM.
Niacin dosing: relationship to benefits and adverse effects.
Curr Atheroscler Rep. 2000 Jan;2(1):64-71. Review.
PMID: 11122726
48: Crawford V, Scheckenbach R, Preuss HG.
Effects of niacin-bound chromium supplementation on body composition in
overweight African-American women.
Diabetes Obes Metab. 1999 Nov;1(6):331-7.
PMID: 11225649
49: Murray MF.
Niacin as a potential AIDS preventive factor.
Med Hypotheses. 1999 Nov;53(5):375-9.
PMID: 10616035
50: Udut VV, Kairov GT, Borodulina EV, V'iugova LM.
[The duration of the action of a single dose of aspirin, kurantil and
nicotinic
acid during pregnancy complicated by EPH gestosis]
Eksp Klin Farmakol. 1999 May-Jun;62(3):37-9. Russian.
PMID: 10439946
51: Sposito AC, Caramelli B, Serrano CV Jr, Mansur AP, Ramires JA.
Effect of niacin and etofibrate association on subjects with coronary
artery
disease and serum high-density lipoprotein cholesterol <35 mg/dl.
Am J Cardiol. 1999 Jan 1;83(1):98-100, A8.
PMID: 10073791
52: Gensler HL, Williams T, Huang AC, Jacobson EL.
Oral niacin prevents photocarcinogenesis and photoimmunosuppression in
mice.
Nutr Cancer. 1999;34(1):36-41.
PMID: 10453439
53: Capuzzi DM, Guyton JR, Morgan JM, Goldberg AC, Kreisberg RA, Brusco
OA, Brody J.
Efficacy and safety of an extended-release niacin (Niaspan): a long-term
study.
Am J Cardiol. 1998 Dec 17;82(12A):74U-81U; discussion 85U-86U.
PMID: 9915666
54: Guyton JR, Capuzzi DM.
Treatment of hyperlipidemia with combined niacin-statin regimens.
Am J Cardiol. 1998 Dec 17;82(12A):82U-84U; discussion 85-86U. Review.
PMID: 9915667
55: Guyton JR.
Effect of niacin on atherosclerotic cardiovascular disease.
Am J Cardiol. 1998 Dec 17;82(12A):18U-23U; discussion 39U-41U. Review.
PMID: 9915658
56: Knopp RH.
Clinical profiles of plain versus sustained-release niacin (Niaspan) and
the
physiologic rationale for nighttime dosing.
Am J Cardiol. 1998 Dec 17;82(12A):24U-28U; discussion 39U-41U. Review.
PMID: 9915659
57: Morgan JM, Capuzzi DM, Guyton JR.
A new extended-release niacin (Niaspan): efficacy, tolerability, and safety
in
hypercholesterolemic patients.
Am J Cardiol. 1998 Dec 17;82(12A):29U-34U; discussion 39U-41U.
PMID: 9915660
58: Goldberg AC.
Clinical trial experience with extended-release niacin (Niaspan):
dose-escalation study.
Am J Cardiol. 1998 Dec 17;82(12A):35U-38U; discussion 39U-41U.
PMID: 9915661
59: Lomnicky Y, Friedman M, Luria MH, Raz I, Hoffman A.
The effect of the mode of administration on the hypolipidaemic activity
of
niacin: continuous gastrointestinal administration of low-dose niacin
improves
lipid-lowering efficacy in experimentally-induced hyperlipidaemic rats.
J Pharm Pharmacol. 1998 Nov;50(11):1233-9.
PMID: 9877308
60: Guyton JR, Goldberg AC, Kreisberg RA, Sprecher DL, Superko HR, O'Connor
CM.
Effectiveness of once-nightly dosing of extended-release niacin alone
and in
combination for hypercholesterolemia.
Am J Cardiol. 1998 Sep 15;82(6):737-43.
PMID: 9761083
61: Philipp CS, Cisar LA, Saidi P, Kostis JB.
Effect of niacin supplementation on fibrinogen levels in patients with
peripheral vascular disease.
Am J Cardiol. 1998 Sep 1;82(5):697-9, A9.
PMID: 9732910
62: Knopp RH, Alagona P, Davidson M, Goldberg AC, Kafonek SD, Kashyap
M,
Sprecher D, Superko HR, Jenkins S, Marcovina S.
Equivalent efficacy of a time-release form of niacin (Niaspan) given
once-a-night versus plain niacin in the management of hyperlipidemia.
Metabolism. 1998 Sep;47(9):1097-104.
PMID: 9751239
63: Chojnowska-Jezierska J, Adamska-Dyniewska H.
Efficacy and safety of one-year treatment with slow-release nicotinic
acid.
Monitoring of drug concentration in serum.
Int J Clin Pharmacol Ther. 1998 Jun;36(6):326-32.
PMID: 9660040
64: Khullar P, Khar RK, Agarwal SP.
Evaluation of hydrogel-based controlled-release niacin tablets.
Drug Dev Ind Pharm. 1998 May;24(5):479-83.
PMID: 9876611
65: Mylonaki-Charalambours E, Mourelatos D, Kotsis A.
A comparative study of the cytogenetic and antineoplasmatic effects induced
by
carboplatin in combination with niacin in human lymphocytes in vitro and
in
Ehrlich ascites tumor cells in vivo.
Chemotherapy. 1998 Mar-Apr;44(2):121-8.
PMID: 9551243
66: Brown BG, Zambon A, Poulin D, Rocha A, Maher VM, Davis JW, Albers
JJ,
Brunzell JD.
Use of niacin, statins, and resins in patients with combined hyperlipidemia.
Am J Cardiol. 1998 Feb 26;81(4A):52B-59B. Review.
PMID: 9526815
67: Drackley JK, LaCount DW, Elliott JP, Klusmeyer TH, Overton TR, Clark
JH,
Blum SA.
Supplemental fat and nicotinic acid for Holstein cows during an entire
lactation.
J Dairy Sci. 1998 Jan;81(1):201-14.
PMID: 9493095
68: [No authors listed]
ASHP Therapeutic Position Statement on the safe use of niacin in the management
of dyslipidemias. American Society of Health-System Pharmacists.
Am J Health Syst Pharm. 1997 Dec 15;54(24):2815-9.
PMID: 9428952
69: Basinskii SN, Krasnogorskaia VN.
[New method of atherosclerotic macular dystrophies treatment]
Vestn Oftalmol. 1997 Nov-Dec;113(6):17-9. Russian.
PMID: 9483992
70: Kegley EB, Spears JW, Eisemann JH.
Performance and glucose metabolism in calves fed a chromium-nicotinic
acid
complex or chromium chloride.
J Dairy Sci. 1997 Aug;80(8):1744-50.
PMID: 9276815
71: Brown BG, Bardsley J, Poulin D, Hillger LA, Dowdy A, Maher VM, Zhao
XQ,
Albers JJ, Knopp RH.
Moderate dose, three-drug therapy with niacin, lovastatin, and colestipol
to
reduce low-density lipoprotein cholesterol <100 mg/dl in patients with
hyperlipidemia and coronary artery disease.
Am J Cardiol. 1997 Jul 15;80(2):111-5.
PMID: 9230143
72: Gardner SF, Marx MA, White LM, Granberry MC, Skelton DR, Fonseca
VA.
Combination of low-dose niacin and pravastatin improves the lipid profile
in
diabetic patients without compromising glycemic control.
Ann Pharmacother. 1997 Jun;31(6):677-82.
PMID: 9184704
73: Johansson JO, Egberg N, Asplund-Carlson A, Carlson LA.
Nicotinic acid treatment shifts the fibrinolytic balance favourably and
decreases plasma fibrinogen in hypertriglyceridaemic men.
J Cardiovasc Risk. 1997 Jun;4(3):165-71.
PMID: 9475670
74: O'Keefe JH, Harris WS.
Nicotinic acid--the underused ally in the fight against coronary disease.
J Cardiovasc Risk. 1997 Jun;4(3):161-3. Review.
PMID: 9475669
75: Mostaza JM, Schulz I, Vega GL, Grundy SM.
Comparison of pravastatin with crystalline nicotinic acid monotherapy
in
treatment of combined hyperlipidemia.
Am J Cardiol. 1997 May 1;79(9):1298-301.
PMID: 9164913
76: O'Connor PJ, Rush WA, Trence DL.
Relative effectiveness of niacin and lovastatin for treatment of dyslipidemias
in a health maintenance organization.
J Fam Pract. 1997 May;44(5):462-7.
PMID: 9152263
77: Aronov DM, Keenan JM, Akhmedzhanov NM, Perova NV, Oganov RY, Kiseleva
NY.
Clinical trial of wax-matrix sustained-release niacin in a Russian population
with hypercholesterolemia.
Arch Fam Med. 1996 Nov-Dec;5(10):567-75.
PMID: 8930228
78: Spencer GA, Wirebaugh S, Whitney EJ.
Effect of a combination of gemfibrozil and niacin on lipid levels.
J Clin Pharmacol. 1996 Aug;36(8):696-700.
PMID: 8877672
79: Gardner SF, Schneider EF, Granberry MC, Carter IR.
Combination therapy with low-dose lovastatin and niacin is as effective
as
higher-dose lovastatin.
Pharmacotherapy. 1996 May-Jun;16(3):419-23.
PMID: 8726600
80: Crouse JR 3rd.
New developments in the use of niacin for treatment of hyperlipidemia:
new
considerations in the use of an old drug.
Coron Artery Dis. 1996 Apr;7(4):321-6. Review.
PMID: 8853585
81: Zhang B, Zhang Q, Lu S.
[Prevention and treatment effect of niacin on FES: experimental study]
Zhonghua Yi Xue Za Zhi. 1996 Jan;76(1):9-12. Chinese.
PMID: 8758455
82: O'Keefe JH Jr, Harris WS, Nelson J, Windsor SL.
Effects of pravastatin with niacin or magnesium on lipid levels and
postprandial lipemia.
Am J Cardiol. 1995 Sep 1;76(7):480-4.
PMID: 7653448
83: Brown WV.
Niacin for lipid disorders. Indications, effectiveness, and safety.
Postgrad Med. 1995 Aug;98(2):185-9, 192-3. Review.
PMID: 7630846
84: Vacek JL, Dittmeier G, Chiarelli T, White J, Bell HH.
Comparison of lovastatin (20 mg) and nicotinic acid (1.2 g) with either
drug
alone for type II hyperlipoproteinemia.
Am J Cardiol. 1995 Jul 15;76(3):182-4.
PMID: 7611158
85: Lal SM, Hewett JE, Petroski GF, Van Stone JC, Ross G Jr.
Effects of nicotinic acid and lovastatin in renal transplant patients:
a
prospective, randomized, open-labeled crossover trial.
Am J Kidney Dis. 1995 Apr;25(4):616-22.
PMID: 7702060
86: Jacobson EL, Dame AJ, Pyrek JS, Jacobson MK.
Evaluating the role of niacin in human carcinogenesis.
Biochimie. 1995;77(5):394-8. Review.
PMID: 8527495
87: Giri SN, Blaisdell R, Rucker RB, Wang Q, Hyde DM.
Amelioration of bleomycin-induced lung fibrosis in hamsters by dietary
supplementation with taurine and niacin: biochemical mechanisms.
Environ Health Perspect. 1994 Dec;102 Suppl 10:137-47.
PMID: 7535685
88: Venkatesan N, Chandrakasan G.
In vivo administration of taurine and niacin modulate cyclophosphamide-induced
lung injury.
Eur J Pharmacol. 1994 Nov 1;292(1):75-80.
PMID: 7867692
89: Tsalamandris C, Panagiotopoulos S, Sinha A, Cooper ME, Jerums G.
Complementary effects of pravastatin and nicotinic acid in the treatment
of
combined hyperlipidaemia in diabetic and non-diabetic patients.
J Cardiovasc Risk. 1994 Oct;1(3):231-9.
PMID: 7621303
90: Gray DR, Morgan T, Chretien SD, Kashyap ML.
Efficacy and safety of controlled-release niacin in dyslipoproteinemic
veterans.
Ann Intern Med. 1994 Aug 15;121(4):252-8.
PMID: 7741833
91: Illingworth DR, Stein EA, Mitchel YB, Dujovne CA, Frost PH, Knopp
RH, Tun P,
Zupkis RV, Greguski RA.
Comparative effects of lovastatin and niacin in primary hypercholesterolemia.
A
prospective trial.
Arch Intern Med. 1994 Jul 25;154(14):1586-95.
PMID: 8031206
92: Jacobson TA, Chin MM, Fromell GJ, Jokubaitis LA, Amorosa LF.
Fluvastatin with and without niacin for hypercholesterolemia.
Am J Cardiol. 1994 Jul 15;74(2):149-54.
PMID: 8023779
93: Singh GR, Menon PS, Shah P, Virmani A.
Early onset juvenile diabetes mellitus controlled with nicotinic acid
therapy.
Indian J Pediatr. 1994 Jul-Aug;61(4):441-2.
PMID: 8002078
94: Schneider F, Popa R, Mihalas G, Stefaniga P, Mihalas IG, Maties R,
Mateescu
R.
Superiority of antagonic-stress composition versus nicergoline in
gerontopsychiatry.
Ann N Y Acad Sci. 1994 Jun 30;717:332-42.
PMID: 8030850
95: Jacobson TA, Jokubaitis LA, Amorosa LF.
Fluvastatin and niacin in hypercholesterolemia: a preliminary report on
gender
differences in efficacy.
Am J Med. 1994 Jun 6;96(6A):64S-68S.
PMID: 8017469
96: Nagai A, Yasui S, Ozawa Y, Uno H, Konno K.
Niacin attenuates acute lung injury induced by lipopolysaccharide in the
hamster.
Eur Respir J. 1994 Jun;7(6):1125-30.
PMID: 7925883
97: Jacobson TA, Amorosa LF.
Combination therapy with fluvastatin and niacin in hypercholesterolemia:
a
preliminary report on safety.
Am J Cardiol. 1994 May 26;73(14):25D-29D.
PMID: 8198020
98: Hultcrantz E, Stenquist M, Lyttkens L.
Sudden deafness: a retrospective evaluation of dextran therapy.
ORL J Otorhinolaryngol Relat Spec. 1994 May-Jun;56(3):137-42.
PMID: 7515486
99: Vega GL, Grundy SM.
Lipoprotein responses to treatment with lovastatin, gemfibrozil, and nicotinic
acid in normolipidemic patients with hypoalphalipoproteinemia.
Arch Intern Med. 1994 Jan 10;154(1):73-82.
PMID: 8267492
100: Kiseleva NG.
[Induracin, prolonged-action nicotinic acid, in the treatment of atherogenic
dyslipoproteinemia]
Klin Med (Mosk). 1994;72(3):20-4. Russian.
PMID: 7990345
101: Mack WJ, Selzer RH, Hodis HN, Erickson JK, Liu CR, Liu CH, Crawford
DW,
Blankenhorn DH.
One-year reduction and longitudinal analysis of carotid intima-media thickness
associated with colestipol/niacin therapy.
Stroke. 1993 Dec;24(12):1779-83.
PMID: 8248954
102: Karmarkar DP, Rajput CS, Wagh SS, Kelkar PS.
Early onset juvenile diabetes mellitus controlled with nicotinic acid
therapy.
Indian J Pediatr. 1993 Nov-Dec;60(6):825-7.
PMID: 8200710
103: Schwartz ML.
Severe reversible hyperglycemia as a consequence of niacin therapy.
Arch Intern Med. 1993 Sep 13;153(17):2050-2.
PMID: 8357290
104: Blankenhorn DH, Selzer RH, Crawford DW, Barth JD, Liu CR, Liu CH,
Mack WJ,
Alaupovic P.
Beneficial effects of colestipol-niacin therapy on the common carotid
artery.
Two- and four-year reduction of intima-media thickness measured by ultrasound.
Circulation. 1993 Jul;88(1):20-8.
PMID: 8319334
105: Franceschini G, Paoletti R.
Pharmacological control of hypertriglyceridemia.
Cardiovasc Drugs Ther. 1993 Jun;7(3):297-302. Review.
PMID: 8364001
106: Schectman G, Hiatt J, Hartz A.
Evaluation of the effectiveness of lipid-lowering therapy (bile acid
sequestrants, niacin, psyllium and lovastatin) for treating hypercholesterolemia
in veterans.
Am J Cardiol. 1993 Apr 1;71(10):759-65.
PMID: 8456750
107: Luria MH, Sapoznikov D.
Raising HDL cholesterol with low-dose nicotinic acid and bezafibrate:
preliminary experience.
Postgrad Med J. 1993 Apr;69(810):296-9.
PMID: 8321794
108: Schmidt EB, Illingworth DR, Bacon S, Russell SJ, Thatcher SR, Mahley
RW,
Weisgraber KH.
Hypolipidemic effects of nicotinic acid in patients with familial defective
apolipoprotein B-100.
Metabolism. 1993 Feb;42(2):137-9.
PMID: 8474308
109: Oganov RG, Kiseleva NG, Aronov DM, Akhmedzhanov NM, Olfer'ev AM,
Kiseleva
NS, Perova NV.
[The use of Enduracin--a prolonged-action form of nicotinic acid--in correcting
atherogenic dyslipidemias]
Kardiologiia. 1993;33(10):54-9, 6. Russian.
PMID: 8139175
110: Wang Q, Hyde DM, Giri SN.
Abatement of bleomycin-induced increases in vascular permeability, inflammatory
cell infiltration, and fibrotic lesions in hamster lungs by combined treatment
with taurine and niacin.
Lab Invest. 1992 Aug;67(2):234-42.
PMID: 1380105
111: Zimmerman CA, Rakes AH, Daniel TE, Hopkins BA.
Influence of dietary protein and supplemental niacin on lactational performance
of cows fed normal and low fiber diets.
J Dairy Sci. 1992 Jul;75(7):1965-78.
PMID: 1323586
112: Wang Q, Hollinger MA, Giri SN.
Attenuation of amiodarone-induced lung fibrosis and phospholipidosis in
hamsters by taurine and/or niacin treatment.
J Pharmacol Exp Ther. 1992 Jul;262(1):127-32.
PMID: 1625191
113: Lavie CJ, Mailander L, Milani RV.
Marked benefit with sustained-release niacin therapy in patients with
"isolated" very low levels of high-density lipoprotein cholesterol
and coronary
artery disease.
Am J Cardiol. 1992 Apr 15;69(12):1083-5.
PMID: 1561983
114: Erickson PS, Murphy MR, Clark JH.
Supplementation of dairy cow diets with calcium salts of long-chain fatty
acids
and nicotinic acid in early lactation.
J Dairy Sci. 1992 Apr;75(4):1078-89.
PMID: 1315811
115: Harms RH, Bootwalla SM.
Research note: performance of single comb White Leghorn pullets as influenced
by niacin supplementation from zero to six weeks of age and subsequent
layer
performance.
Poult Sci. 1992 Apr;71(4):771-4.
PMID: 1594529
116: Keenan JM, Wenz JB, Ripsin CM, Huang Z, McCaffrey DJ.
A clinical trial of oat bran and niacin in the treatment of hyperlipidemia.
J Fam Pract. 1992 Mar;34(3):313-9.
PMID: 1541958
117: Bassler TJ.
Niacin benefits.
West J Med. 1992 Feb;156(2):209.
PMID: 1536086
118: Giri SN, Wang Q.
Taurine and niacin offer a novel therapeutic modality in prevention of
chemically-induced pulmonary fibrosis in hamsters.
Adv Exp Med Biol. 1992;315:329-40.
PMID: 1380762
119: Keenan JM, Bae CY, Fontaine PL, Wenz JB, Myers S, Huang ZQ, Ripsin
C.
Treatment of hypercholesterolemia: comparison of younger versus older
patients
using wax-matrix sustained-release niacin.
J Am Geriatr Soc. 1992 Jan;40(1):12-8.
PMID: 1727841
120: Yersin AG, Edens FW, Simmons DG.
Tracheal cilia response to exogenous niacin in drinking water of turkey
poults
infected with Bordetella avium.
Avian Dis. 1991 Oct-Dec;35(4):674-80.
PMID: 1785998
121: Krishnamurthy A, Thapar GS.
Effect of bezafibrate & nicotinic acid on triton induced hyperlipidemias
in CFY
rats.
Indian J Med Res. 1991 Oct;94:395-8.
PMID: 1794899
122: Henkin Y, Oberman A, Hurst DC, Segrest JP.
Niacin revisited: clinical observations on an important but underutilized
drug.
Am J Med. 1991 Sep;91(3):239-46.
PMID: 1892143
123: Wang QJ, Giri SN, Hyde DM, Li C.
Amelioration of bleomycin-induced pulmonary fibrosis in hamsters by combined
treatment with taurine and niacin.
Biochem Pharmacol. 1991 Aug 8;42(5):1115-22.
PMID: 1714734
124: Keenan JM, Fontaine PL, Wenz JB, Myers S, Huang ZQ, Ripsin CM.
Niacin revisited. A randomized, controlled trial of wax-matrix
sustained-release niacin in hypercholesterolemia.
Arch Intern Med. 1991 Jul;151(7):1424-32.
PMID: 2064495
125: Drood JM, Zimetbaum PJ, Frishman WH.
Nicotinic acid for the treatment of hyperlipoproteinemia.
J Clin Pharmacol. 1991 Jul;31(7):641-50. Review.
PMID: 1894760
126: Blankenhorn DH, Azen SP, Crawford DW, Nessim SA, Sanmarco ME, Selzer
RH,
Shircore AM, Wickham EC.
Effects of colestipol-niacin therapy on human femoral atherosclerosis.
Circulation. 1991 Feb;83(2):438-47.
PMID: 1991366
127: Capurso A.
Drugs affecting triglycerides.
Cardiology. 1991;78(3):218-25. Review.
PMID: 1868499
128: Berge KG, Canner PL.
Coronary drug project: experience with niacin. Coronary Drug Project Research
Group.
Eur J Clin Pharmacol. 1991;40 Suppl 1:S49-51.
PMID: 2044644
129: Ajayi AA, Akinleye AO, Udoh SJ, Ajayi OO, Oyelese O, Ijaware CO.
The effects of prednisolone and niacin on chloroquine-induced pruritus
in
malaria.
Eur J Clin Pharmacol. 1991;41(4):383-5.
PMID: 1804657
130: Palumbo PJ.
Rediscovery of crystalline niacin.
Mayo Clin Proc. 1991 Jan;66(1):112-3.
PMID: 1988752
131: Cashin-Hemphill L, Mack WJ, Pogoda JM, Sanmarco ME, Azen SP, Blankenhorn
DH.
Beneficial effects of colestipol-niacin on coronary atherosclerosis. A
4-year
follow-up.
JAMA. 1990 Dec 19;264(23):3013-7.
PMID: 2243429
132: Chernomorets NN, Kotlubei GV, Vatutin NT, Zhivotovskaia IA, Gnilitskaia
VB,
Alifanova RE, Lobach EIa, Mal'tseva NV, Mitrofanov AN.
[The effect of tocopherol and nicotinic acid on the microcirculation and
blood
coagulability in patients with ischemic heart disease]
Vrach Delo. 1990 Dec;(12):6-8. Russian.
PMID: 2089804
133: Tornvall P, Hamsten A, Johansson J, Carlson LA.
Normalisation of the composition of very low density lipoprotein in
hypertriglyceridemia by nicotinic acid.
Atherosclerosis. 1990 Oct;84(2-3):219-27.
PMID: 2282100
134: Wu FF, Gray DR.
Promotion of extended-release niacin tablets at a Veterans Affairs medical
center.
Am J Hosp Pharm. 1990 Sep;47(9):2031-4.
PMID: 2220857
135: Garg A, Grundy SM.
Nicotinic acid as therapy for dyslipidemia in non-insulin-dependent diabetes
mellitus.
JAMA. 1990 Aug 8;264(6):723-6.
PMID: 2374275
136: Johansson J, Carlson LA.
The effects of nicotinic acid treatment on high density lipoprotein particle
size subclass levels in hyperlipidaemic subjects.
Atherosclerosis. 1990 Aug;83(2-3):207-16.
PMID: 2242098
137: Wahlberg G, Walldius G, Olsson AG, Kirstein P.
Effects of nicotinic acid on serum cholesterol concentrations of high
density
lipoprotein subfractions HDL2 and HDL3 in hyperlipoproteinaemia.
J Intern Med. 1990 Aug;228(2):151-7.
PMID: 2394966
138: Ruiz N, Harms RH, Linda SB.
Niacin requirement of broiler chickens fed a corn-soybean meal diet from
1 to
21 days of age.
Poult Sci. 1990 Mar;69(3):433-9.
PMID: 2345725
139: Im MJ, Hoopes JE.
Improved skin flap survival with nicotinic acid and nicotinamide in rats.
J Surg Res. 1989 Nov;47(5):453-5.
PMID: 2530401
140: Alderman JD, Pasternak RC, Sacks FM, Smith HS, Monrad ES, Grossman
W.
Effect of a modified, well-tolerated niacin regimen on serum total cholesterol,
high density lipoprotein cholesterol and the cholesterol to high density
lipoprotein ratio.
Am J Cardiol. 1989 Oct 1;64(12):725-9.
PMID: 2801522
141: Kats GL, Zhivotovskaia IA, Gnilitskaia VB, Alifanova RE, Mal'tseva
NV.
[Nicotinic acid in the treatment of chronic circulatory failure in patients
with ischemic heart disease]
Vrach Delo. 1989 Sep;(9):16-9. Russian.
PMID: 2609611
142: Taguchi S, Wada T, Kijima S, Yoshie H, Hara K, Tonomura M, Tsujita
S.
[Effects of nicotinate ethyl ester treatment on gingival blood circulation
of
experimental gingivitis in monkeys]
Nippon Shishubyo Gakkai Kaishi. 1989 Mar;31(1):184-99. Japanese.
PMID: 2517791
143: Datta S, Das DK, Engelman RM, Otani H, Rousou JA, Breyer RH, Klar
J.
Enhanced myocardial preservation by nicotinic acid, an antilipolytic compound:
mechanism of action.
Basic Res Cardiol. 1989 Jan-Feb;84(1):63-76.
PMID: 2923608
144: Urberg M, Benyi J, John R.
Hypocholesterolemic effects of nicotinic acid and chromium supplementation.
J Fam Pract. 1988 Dec;27(6):603-6.
PMID: 3199088
145: Luria MH.
Effect of low-dose niacin on high-density lipoprotein cholesterol and
total
cholesterol/high-density lipoprotein cholesterol ratio.
Arch Intern Med. 1988 Nov;148(11):2493-5.
PMID: 3190381
146: Alekseeva IA, Katserikova NV, Grishchenko NL, Isaeva VA, Klimova
OA.
[Experimental evaluation of the effectiveness of vitamin-enriched chopped
meat
products]
Vopr Pitan. 1988 Jul-Aug;(4):55-9. Russian.
PMID: 3232340
147: Mamedov IaD, Garaev GSh, Korkmazov BM, Mirzabekova FI.
[The structuro-functional state of the ischemic myocardium under the action
of
a terrilitin-nicotinic acid mixture in animal experiments]
Biull Eksp Biol Med. 1988 May;105(5):618-20. Russian.
PMID: 2454688
148: Rachkov AK.
[Metabolic effects of succinic and nicotinic acids in emotional pain stress]
Farmakol Toksikol. 1988 May-Jun;51(3):41-5. Russian.
PMID: 3410024
149: Flachowsky G, Matthey M, Ochrimenko WI.
Influence of dietary niacin on volatile fatty acids in rumen liquid of
sheep
and rumen dry matter degradability of untreated and ammonia-treated wheat
straw.
Arch Tierernahr. 1988 Feb;38(2):99-108.
PMID: 2837166
150: Cohen L, Morgan J.
Effectiveness of individualized long-term therapy with niacin and probucol
in
reduction of serum cholesterol.
J Fam Pract. 1988 Feb;26(2):145-50.
PMID: 3339318
151: Carpenter KJ, Schelstraete M, Vilicich VC, Wall JS.
Immature corn as a source of niacin for rats.
J Nutr. 1988 Feb;118(2):165-9.
PMID: 3339473
152: Figge HL, Figge J, Souney PF, Mutnick AH, Sacks F.
Nicotinic acid: a review of its clinical use in the treatment of lipid
disorders.
Pharmacotherapy. 1988;8(5):287-94. Review.
PMID: 3075276
153: Malloy MJ, Kane JP, Kunitake ST, Tun P.
Complementarity of colestipol, niacin, and lovastatin in treatment of
severe
familial hypercholesterolemia.
Ann Intern Med. 1987 Nov;107(5):616-23.
PMID: 3662275
154: Blankenhorn DH, Nessim SA, Johnson RL, Sanmarco ME, Azen SP,
Cashin-Hemphill L.
Beneficial effects of combined colestipol-niacin therapy on coronary
atherosclerosis and coronary venous bypass grafts.
JAMA. 1987 Jun 19;257(23):3233-40. Erratum in: JAMA 1988 May 13;259(18):2698.
PMID: 3295315
155: Canner PL, Berge KG, Wenger NK, Stamler J, Friedman L, Prineas RJ,
Friedewald W.
Fifteen year mortality in Coronary Drug Project patients: long-term benefit
with niacin.
J Am Coll Cardiol. 1986 Dec;8(6):1245-55.
PMID: 3782631
156: Tlepshukov IK.
[Effect of heparin on the vascular thrombocytic link of the hemostatic
system
and pathogenetic correction of ensuing disorders]
Biull Eksp Biol Med. 1986 Nov;102(11):544-5. Russian.
PMID: 3779075
157: Angelin B, Eriksson M, Einarsson K.
Combined treatment with cholestyramine and nicotinic acid in heterozygous
familial hypercholesterolaemia: effects on biliary lipid composition.
Eur J Clin Invest. 1986 Oct;16(5):391-6.
PMID: 3100307
158: Vik-Mo H, Mjos OD, Neely JR, Maroko PR, Ribeiro LG.
Limitation of myocardial infarct size by metabolic interventions that
reduce
accumulation of fatty acid metabolites in ischemic myocardium.
Am Heart J. 1986 Jun;111(6):1048-54.
PMID: 3716978
159: Ruegsegger GJ, Schultz LH.
Use of a combination of propylene glycol and niacin for subclinical ketosis.
J Dairy Sci. 1986 May;69(5):1411-5.
PMID: 3722549
160: Chekalina SI, Guseva LI, Bardyechev MS.
[Use of nicotinic acid and midocalm for correcting blood coagulation in
patients with radiation edema of the extremities]
Med Radiol (Mosk). 1985 Aug;30(8):28-30. Russian.
PMID: 4033386
161: Koch MO, McDougal WS.
Nicotinic acid: treatment for the hyperchloremic acidosis following urinary
diversion through intestinal segments.
J Urol. 1985 Jul;134(1):162-4.
PMID: 4009816
162: Knopp RH, Ginsberg J, Albers JJ, Hoff C, Ogilvie JT, Warnick GR,
Burrows E,
Retzlaff B, Poole M.
Contrasting effects of unmodified and time-release forms of niacin on
lipoproteins in hyperlipidemic subjects: clues to mechanism of action
of niacin.
Metabolism. 1985 Jul;34(7):642-50.
PMID: 3925290
163: Nikulin AA, Rachkov AK.
[Metabolic effects of nicotinic acid in different types of experimental
vascular pathology in rabbits]
Farmakol Toksikol. 1985 May-Jun;48(3):69-74. Russian.
PMID: 2411593
164: Walldius G, Wahlberg G.
Effects of nicotinic acid and its derivatives on lipid metabolism and
other
metabolic factors related to atherosclerosis.
Adv Exp Med Biol. 1985;183:281-93.
PMID: 4036701
165: Orbetsova V, Iurukova Ts, Kirov T.
[Regression of experimental cholesterol-induced atherosclerosis in rabbits
after stopping the atherogenic diet and after treatment with nicotinic
acid]
Eksp Med Morfol. 1985;24(1):32-8. Bulgarian.
PMID: 4029068
166: Hoeg JM, Maher MB, Bou E, Zech LA, Bailey KR, Gregg RE, Sprecher
DL, Susser
JK, Pikus AM, Brewer HB Jr.
Normalization of plasma lipoprotein concentrations in patients with type
II
hyperlipoproteinemia by combined use of neomycin and niacin.
Circulation. 1984 Dec;70(6):1004-11.
PMID: 6388897
167: Dufva GS, Bartley EE, Nagaraja TG, Dayton AD, Frey RA.
Effect of dietary niacin supplementation on phlorhizin and
1,3-butanediol-induced ketonemia and hypoglycemia in steers.
Am J Vet Res. 1984 Sep;45(9):1835-7.
PMID: 6497141
168: Hoogwerf BJ, Bantle JP, Kuba K, Frantz ID Jr, Hunninghake DB.
Treatment of type III hyperlipoproteinemia with four different treatment
regimens.
Atherosclerosis. 1984 May-Jun;51(2-3):251-9.
PMID: 6588975
169: Kresiun VI.
[Stress-protective properties of lithium nicotinate--a new derivative
of
nicotinic acid]
Biull Eksp Biol Med. 1984 Mar;97(3):312-5. Russian.
PMID: 6538449
170: Odetti P, Cheli V, Carta G, Maiello M, Viviani GL.
Effect of nicotinic acid associated with retinol and tocopherols on plasma
lipids in hyperlipoproteinaemic patients.
Pharmatherapeutica. 1984;4(1):21-4.
PMID: 6390462
171: Goranov Kh, Gabrovski P, Zheliazkov S, Popgeorgieva M.
[Therapeutic and prophylactic action of monensin and nicotinic acid in
cows
with subclinical ketosis]
Vet Med Nauki. 1984;21(1):43-50. Bulgarian.
PMID: 6730318
172: Farber FM.
[Treatment of primary neuritis of the facial nerve with compresses of
dimexide
and nicotinic acid]
Zh Nevropatol Psikhiatr Im S S Korsakova. 1984;84(8):1161-3. Russian.
PMID: 6495938
173: Rabbani GH, Butler T, Bardhan PK, Islam A.
Reduction of fluid-loss in cholera by nicotinic acid: a randomised controlled
trial.
Lancet. 1983 Dec 24-31;2(8365-66):1439-42.
PMID: 6140541
174: Nessim SA, Chin HP, Alaupovic P, Blankenhorn DH.
Combined therapy of niacin, colestipol, and fat-controlled diet in men
with
coronary bypass. Effect on blood lipids and apolipoproteins.
Arteriosclerosis. 1983 Nov-Dec;3(6):568-73.
PMID: 6651612
175: Maksimovich IaB, Kresiun VI, Ariaev VL.
[Biochemical disturbances in the chronic use of alcohol and ways to correct
them]
Ukr Biokhim Zh. 1983 Nov-Dec;55(6):643-6. Russian.
PMID: 6229075
176: Walker AR, Walker BF, Metz J.
Acceptability trials of maize meal fortified with niacin, riboflavin and
folic
acid.
S Afr Med J. 1983 Sep 3;64(10):343-6.
PMID: 6612529
177: Maksimovich IaB, Kresiun VI, Ariaev VL.
[Effectiveness of lithium nicotinate in the treatment of experimental
alcoholism]
Biull Eksp Biol Med. 1983 Aug;96(8):35-7. Russian.
PMID: 6683980
178: Feeding supplemental niacin for milk production in six dairy herds.
J Dairy Sci. 1983 May;66(5):1046-51.
PMID: 6875057
179: Jaster EH, Bell DF, McPherron TA.
Nicotinic acid and serum metabolite concentrations of lactating dairy
cows fed
supplemental niacin.
J Dairy Sci. 1983 May;66(5):1039-45.
PMID: 6875056
180: Shafer RB, Knodell RG, Stanley LN, Elson MK.
Acute effects of nicotinic acid on hepatic transport of 99mTc-PIPIDA.
Eur J Nucl Med. 1983;8(1):12-4.
PMID: 6832182
181: Kiuchi K, Kondo M, Ueno S, Moriguchi K, Yoshizawa K, Miyake Y, Matsumura
M,
Tsubura A.
Functional rescue of N-methyl-N-nitrosourea-induced retinopathy by nicotinamide
in Sprague-Dawley rats.
Curr Eye Res. 2003 Jun;26(6):355-62.
PMID: 12868016
182: Isbir CS, Ak K, Kurtkaya O, Zeybek U, Akgun S, Scheitauer BW, Sav
A,
Cobanoglu A.
Ischemic preconditioning and nicotinamide in spinal cord protection in
an
experimental model of transient aortic occlusion.
Eur J Cardiothorac Surg. 2003 Jun;23(6):1028-33.
PMID: 12829083
183: Steensrud T, Nordhaug D, Elvenes OP, Korvald C, Sorlie DG.
Superior myocardial protection with nicorandil cardioplegia.
Eur J Cardiothorac Surg. 2003 May;23(5):670-7.
PMID: 12754016
184: Grote W, Claussen U, Heinz D.
[Induction and prevention of developmental abnormalities in rabbits by
administration of 6-aminonicotinic acid and nicotinic acid amide]
Arzneimittelforschung. 1971 Jun;21(6):825-8. German.
PMID: 4327352
185: Wajima Z, Yoshikawa T, Ogura A, Imanaga K, Shiga T, Inoue T, Ogawa
R.
Intravenous nicorandil prevents thiamylal-fentanyl-induced bronchoconstriction
in humans.
Crit Care Med. 2003 Feb;31(2):485-90.
PMID: 12576956
186: Kurisu S, Inoue I, Kawagoe T, Ishihara M, Shimatani Y, Nishioka
K, Nakamura
S, Umemura T, Yoshida M.
Usefulness of massive oral nicorandil in a patient with variant angina
refractory to conventional treatment.
Intern Med. 2003 Feb;42(2):163-7.
PMID: 12636235
187: Beal MF.
Bioenergetic approaches for neuroprotection in Parkinson's disease.
Ann Neurol. 2003;53 Suppl 3:S39-47; discussion S47-8. Review.
PMID: 12666097
188: Ungerstedt JS, Blomback M, Soderstrom T.
Nicotinamide is a potent inhibitor of proinflammatory cytokines.
Clin Exp Immunol. 2003 Jan;131(1):48-52.
PMID: 12519385
189: Falsini B, Piccardi M, Iarossi G, Fadda A, Merendino E, Valentini
P.
Influence of short-term antioxidant supplementation on macular function
in
age-related maculopathy: a pilot study including electrophysiologic assessment.
Ophthalmology. 2003 Jan;110(1):51-60; discussion 61.
PMID: 12511345
190: Sakamoto K, Mori K, Hashimoto T, Yancey KB, Nakashima T.
Antiepiligrin cicatricial pemphigoid of the larynx successfully treated
with a
combination of tetracycline and niacinamide.
Arch Otolaryngol Head Neck Surg. 2002 Dec;128(12):1420-3.
PMID: 12479732
191: Tsubokawa A, Ueda K, Sakamoto H, Iwase T, Tamaki S.
Effect of intracoronary nicorandil administration on preventing no-reflow/slow
flow phenomenon during rotational atherectomy.
Circ J. 2002 Dec;66(12):1119-23.
PMID: 12499617
192: Hausermann P, Gutersohn T, Beltraminelli H, Schiller P, Buchner
SA, Rufli
T.
[Oral pemphigus vulgaris. Successful treatment with minocycline and
nicotinamide]
Hautarzt. 2002 Dec;53(12):813-5. German.
PMID: 12444523
193: Kawai Y, Hayashi Y, Ito I, Kamibayashi T, Takada K, Kagawa K, Yamatodani
A,
Mashimo T.
Nicorandil prevents epinephrine-induced arrhythmias in halothane-anesthetized
rats by nitric oxide-dependent mechanism.
Naunyn Schmiedebergs Arch Pharmacol. 2002 Dec;366(6):522-7. Epub 2002
Oct 17.
PMID: 12444492
194: Yang J, Klaidman LK, Chang ML, Kem S, Sugawara T, Chan P, Adams
JD.
Nicotinamide therapy protects against both necrosis and apoptosis in a
stroke
model.
Pharmacol Biochem Behav. 2002 Nov;73(4):901-10.
PMID: 12213537
195: Amato L, Coronella G, Berti S, Gallerani I, Moretti S, Fabbri P.
Successful treatment with doxycycline and nicotinamide of two cases of
persistent pemphigoid gestationis.
J Dermatolog Treat. 2002 Sep;13(3):143-6.
PMID: 12227878
196: Hakozaki T, Minwalla L, Zhuang J, Chhoa M, Matsubara A, Miyamoto
K,
Greatens A, Hillebrand GG, Bissett DL, Boissy RE.
The effect of niacinamide on reducing cutaneous pigmentation and suppression
of
melanosome transfer.
Br J Dermatol. 2002 Jul;147(1):20-31.
PMID: 12100180
197: Sakakibara Y, Mitha AP, Ayoub IA, Ogilvy CS, Maynard KI.
Delayed treatment with nicotinamide (vitamin B3) reduces the infarct volume
following focal cerebral ischemia in spontaneously hypertensive rats,
diabetic
and non-diabetic Fischer 344 rats.
Brain Res. 2002 Mar 22;931(1):68-73.
PMID: 11897090
198: Kiuchi K, Yoshizawa K, Shikata N, Matsumura M, Tsubura A.
Nicotinamide prevents N-methyl-N-nitrosourea-induced photoreceptor cell
apoptosis in Sprague-Dawley rats and C57BL mice.
Exp Eye Res. 2002 Mar;74(3):383-92.
PMID: 12014919
199: Kaanders JH, Pop LA, Marres HA, Bruaset I, van den Hoogen FJ, Merkx
MA, van
der Kogel AJ.
ARCON: experience in 215 patients with advanced head-and-neck cancer.
Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):769-78.
PMID: 11849800
200: Ayoub IA, Maynard KI.
Therapeutic window for nicotinamide following transient focal cerebral
ischemia.
Neuroreport. 2002 Feb 11;13(2):213-6.
PMID: 11893912
201: Loo WJ, Dean D, Wojnarowska F.
A severe persistent case of recurrent pemphigoid gestationis successfully
treated with minocycline and nicotinamide.
Clin Exp Dermatol. 2001 Nov;26(8):726-7.
PMID: 11722465
202: Hassan N, Janjua MZ.
The optimum dose of nicotinamide for protection of pancreatic beta-cells
against the cytotoxic effect of streptozotocin in albino rat.
J Ayub Med Coll Abbottabad. 2001 Jul-Sep;13(3):26-30.
PMID: 11873395
203: Khanna N, Pandhi RK, Gupta S, Singh MK.
Response of chronic bullous dermatosis of childhood to a combination of
dapsone
and nicotinamide.
J Eur Acad Dermatol Venereol. 2001 Jul;15(4):368.
PMID: 11730061
204: Murray MF, Langan M, MacGregor RR.
Increased plasma tryptophan in HIV-infected patients treated with pharmacologic
doses of nicotinamide.
Nutrition. 2001 Jul-Aug;17(7-8):654-6.
PMID: 11448590
205: Maynard KI, Ayoub IA, Shen CC.
Delayed multidose treatment with nicotinamide extends the degree and duration
of neuroprotection by reducing infarction and improving behavioral scores
up to
two weeks following transient focal cerebral ischemia in Wistar rats.
Ann N Y Acad Sci. 2001 Jun;939:416-24.
PMID: 11462797
206: Kreyden OP, Borradori L, Trueb RM, Burg G, Nestle FO.
[Successful therapy with tetracycline and nicotinamide in cicatricial
pemphigoid]
Hautarzt. 2001 Mar;52(3):247-50. German.
PMID: 11284073
207: Izu K, Yamamoto O, Masuyuki K, Asahi M, Komai R, Yasumoto S, Hashimoto
T.
[A case of pemphigus foliaceus associated with bullous impetigo successfully
treated with tetracycline and nicotinamide]
J UOEH. 2001 Mar 1;23(1):59-67. Japanese.
PMID: 11279842
208: Reddy S, Karanam M, Robinson E.
Prevention of cyclophosphamide-induced accelerated diabetes in the NOD
mouse by
nicotinamide or a soy protein-based infant formula.
Int J Exp Diabetes Res. 2001;1(4):299-313.
PMID: 11467420
To here
209: Knip M, Douek IF, Moore WP, Gillmor HA, McLean AE, Bingley PJ, Gale
EA;
European Nicotinamide Diabetes Intervention Trial Group.
Safety of high-dose nicotinamide: a review.
Diabetologia. 2000 Nov;43(11):1337-45. Review.
PMID: 11126400
210: Goon AT, Tan SH, Khoo LS, Tan T.
Tetracycline and nicotinamide for the treatment of bullous pemphigoid:
our
experience in Singapore.
Singapore Med J. 2000 Jul;41(7):327-30.
PMID: 11026799
211: Bouzas EA, Karadimas P, Mastorakos G, Koutras DA.
Antioxidant agents in the treatment of Graves' ophthalmopathy.
Am J Ophthalmol. 2000 May;129(5):618-22.
PMID: 10844053
212: Shah SA, Ormerod AD.
Dermatitis herpetiformis effectively treated with heparin, tetracycline
and
nicotinamide.
Clin Exp Dermatol. 2000 May;25(3):204-5.
PMID: 10844495
213: O'Brien BA, Harmon BV, Cameron DP, Allan DJ.
Nicotinamide prevents the development of diabetes in the
cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis.
J Pathol. 2000 May;191(1):86-92.
PMID: 10767724
214: Malcon C, Kaddurah-Daouk R, Beal MF.
Neuroprotective effects of creatine administration against NMDA and malonate
toxicity.
Brain Res. 2000 Mar 31;860(1-2):195-8.
PMID: 10727643
215: Sakakibara Y, Mitha AP, Ogilvy CS, Maynard KI.
Post-treatment with nicotinamide (vitamin B(3)) reduces the infarct volume
following permanent focal cerebral ischemia in female Sprague-Dawley and
Wistar
rats.
Neurosci Lett. 2000 Mar 10;281(2-3):111-4.
PMID: 10704755
216: McCarty MF, Russell AL.
Niacinamide therapy for osteoarthritis--does it inhibit nitric oxide synthase
induction by interleukin 1 in chondrocytes?
Med Hypotheses. 1999 Oct;53(4):350-60.
PMID: 10608273
217: Yomada M, Komai A, Hashimato T.
Sublamina densa-type linear IgA bullous dermatosis successfully treated
with
oral tetracycline and niacianamide.
Br J Dermatol. 1999 Sep;141(3):608-9.
PMID: 10583104
218: Cuzzocrea S, Zingarelli B, Costantino G, Sottile A, Teti D, Caputi
AP.
Protective effect of poly(ADP-ribose) synthetase inhibition on multiple
organ
failure after zymosan-induced peritonitis in the rat.
Crit Care Med. 1999 Aug;27(8):1517-23.
PMID: 10470759
219: Kroger H, Hauschild A, Ohde M, Bache K, Voigt WP, Thefeldt W, Kruger
D.
Nicotinamide and methionine reduce the liver toxic effect of methotrexate.
Gen Pharmacol. 1999 Aug;33(2):203-6.
PMID: 10461859
220: Visalli N, Cavallo MG, Signore A, Baroni MG, Buzzetti R, Fioriti
E,
Mesturino C, Fiori R, Lucentini L, Matteoli MC, Crino A, Corbi S, Spera
S,
Teodonio C, Paci F, Amoretti R, Pisano L, Suraci C, Multari G, Sulli N,
Cervoni
M, De Mattia G, Faldetta MR, Boscherini B, Pozzilli P, et al.
A multi-centre randomized trial of two different doses of nicotinamide
in
patients with recent-onset type 1 diabetes (the IMDIAB VI).
Diabetes Metab Res Rev. 1999 May-Jun;15(3):181-5.
PMID: 10441040
221: Dragan L, Eng AM, Lam S, Persson T.
Tetracycline and niacinamide: treatment alternatives in ocular cicatricial
pemphigoid.
Cutis. 1999 Mar;63(3):181-3.
PMID: 10190074
222: Kolb H, Burkart V.
Nicotinamide in type 1 diabetes. Mechanism of action revisited.
Diabetes Care. 1999 Mar;22 Suppl 2:B16-20. Review.
PMID: 10097894
223: Ayoub IA, Lee EJ, Ogilvy CS, Beal MF, Maynard KI.
Nicotinamide reduces infarction up to two hours after the onset of permanent
focal cerebral ischemia in Wistar rats.
Neurosci Lett. 1999 Jan 4;259(1):21-4.
PMID: 10027546
224: Beales PE, Burr LA, Webb GP, Mansfield KJ, Pozzilli P.
Diet can influence the ability of nicotinamide to prevent diabetes in
the
non-obese diabetic mouse: a preliminary study.
Diabetes Metab Res Rev. 1999 Jan-Feb;15(1):21-8.
PMID: 10398543
225: el-Said A, Menke D, Dorie MJ, Brown JM.
Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide
in enhancing the response of a human tumor xenograft to fractionated
irradiation.
Radiat Oncol Investig. 1999;7(3):163-9.
PMID: 10406058
226: Loginov AS, Matiushin BN, Astaf'eva OV, Nilova TV, Vinokurova LV.
[Nicotinamide in combined treatment of chronic pancreatitis]
Ter Arkh. 1999;71(8):43-6. Russian.
PMID: 10515036
227: Reiche L, Wojnarowska F, Mallon E.
Combination therapy with nicotinamide and tetracyclines for cicatricial
pemphigoid: further support for its efficacy.
Clin Exp Dermatol. 1998 Nov;23(6):254-7.
PMID: 10233619
228: Pasmans SG, Preesman AH, van Vloten WA.
[Pellagra (deficiency of vitamin B3 or of the amino acid tryptophan):
a disease
still extant in the Netherlands]
Ned Tijdschr Geneeskd. 1998 Aug 15;142(33):1880-2. Dutch.
PMID: 9856171
229: Honl BA, Elston DM.
Autoimmune bullous eruption localized to a breast reconstruction site:
response
to niacinamide.
Cutis. 1998 Aug;62(2):85-6.
PMID: 9714904
230: Kaanders JH, Pop LA, Marres HA, Liefers J, van den Hoogen FJ, van
Daal WA,
van der Kogel AJ.
Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal
cancer.
Radiother Oncol. 1998 Aug;48(2):115-22.
PMID: 9783882
231: Lampeter EF, Klinghammer A, Scherbaum WA, Heinze E, Haastert B,
Giani G,
Kolb H.
The Deutsche Nicotinamide Intervention Study: an attempt to prevent type
1
diabetes. DENIS Group.
Diabetes. 1998 Jun;47(6):980-4.
PMID: 9604880
232: Polo V, Saibene A, Pontiroli AE.
Nicotinamide improves insulin secretion and metabolic control in lean
type 2
diabetic patients with secondary failure to sulphonylureas.
Acta Diabetol. 1998 Apr;35(1):61-4.
PMID: 9625292
233: Rothstein E, Scott DW, Riis RC.
Tetracycline and niacinamide for the treatment of sterile
pyogranuloma/granuloma syndrome in a dog.
J Am Anim Hosp Assoc. 1997 Nov-Dec;33(6):540-3.
PMID: 9358425
234: McLaren DB, Pickles T, Thomson T, Olive PL.
Impact of nicotinamide on human tumour hypoxic fraction measured using
the
comet assay.
Radiother Oncol. 1997 Nov;45(2):175-82.
PMID: 9424009
235: Horsman MR, Siemann DW, Chaplin DJ, Overgaard J.
Nicotinamide as a radiosensitizer in tumours and normal tissues: the importance
of drug dose and timing.
Radiother Oncol. 1997 Nov;45(2):167-74.
PMID: 9424008
236: Saunders MI, Hoskin PJ, Pigott K, Powell ME, Goodchild K, Dische
S,
Denekamp J, Stratford MR, Dennis MF, Rojas AM.
Accelerated radiotherapy, carbogen and nicotinamide (ARCON) in locally
advanced
head and neck cancer: a feasibility study.
Radiother Oncol. 1997 Nov;45(2):159-66.
PMID: 9424007
237: Pozzilli P, Visalli N, Cavallo MG, Signore A, Baroni MG, Buzzetti
R,
Fioriti E, Mesturino C, Fiori R, Romiti A, Giovannini C, Lucentini L,
Matteoli
MC, Crino A, Teodonio C, Paci F, Amoretti R, Pisano L, Suraci C, Multari
G,
Suppa M, Sulli N, De Mattia G, Faldetta MR, Suraci MT.
Vitamin E and nicotinamide have similar effects in maintaining residual
beta
cell function in recent onset insulin-dependent diabetes (the IMDIAB IV
study)
Eur J Endocrinol. 1997 Sep;137(3):234-9. Erratum in: Eur J Endocrinol
1997
Nov;137(5):558.
PMID: 9330586
238: Kim JY, Chi JK, Kim EJ, Park SY, Kim YW, Lee SK.
Inhibition of diabetes in non-obese diabetic mice by nicotinamide treatment
for
5 weeks at the early age.
J Korean Med Sci. 1997 Aug;12(4):293-7.
PMID: 9288627
239: Masunaga S, Ono K, Akaboshi M, Kawai K, Suzuki M, Kinashi Y, Takagaki
M.
Augmentation in chemosensitivity of intratumor quiescent cells by combined
treatment with nicotinamide and mild hyperthermia.
Jpn J Cancer Res. 1997 Aug;88(8):770-7.
PMID: 9330609
240: Masunaga S, Ono K, Suzuki M, Takagaki M, Sakurai Y, Kobayashi T,
Akuta K,
Akaboshi M, Kinashi Y, Abe M.
Modification of the response of a quiescent cell population within a murine
solid tumour to boron neutron capture irradiation: studies with nicotinamide
and
hyperthermia.
Br J Radiol. 1997 Apr;70(832):391-8.
PMID: 9166076
241: Legon'kova LF, Bushma MI, Zverinskii IV, Abakumov GZ, Zavodnik LV.
[The effect of nicotinamide, methionine and alpha-tocopherol on the liver
conjugating and mono-oxygenase systems and on lipid peroxidation in
hepatosis-hepatitis in rats]
Eksp Klin Farmakol. 1997 Mar-Apr;60(2):68-71. Russian.
PMID: 9206576
242: Fatigante L, Ducci F, Cartei F, Colosimo S, Marini C, Prediletto
R, Danesi
R, Laddaga M, Del Tacca M, Caciagli P.
Carbogen and nicotinamide combined with unconventional radiotherapy in
glioblastoma multiforme: a new modality treatment.
Int J Radiat Oncol Biol Phys. 1997 Feb 1;37(3):499-504.
PMID: 9112444
243: Denekamp J, Fowler JF.
ARCON--current status: summary of a workshop on preclinical and clinical
studies.
Acta Oncol. 1997;36(5):517-25. Review.
PMID: 9292749
244: Hoskin PJ, Saunders MI, Phillips H, Cladd H, Powell ME, Goodchild
K,
Stratford MR, Rojas A.
Carbogen and nicotinamide in the treatment of bladder cancer with radical
radiotherapy.
Br J Cancer. 1997;76(2):260-3.
PMID: 9231929
245: Pozzilli P, Browne PD, Kolb H.
Meta-analysis of nicotinamide treatment in patients with recent-onset
IDDM. The
Nicotinamide Trialists.
Diabetes Care. 1996 Dec;19(12):1357-63.
PMID: 8941464
246: Hu Y, Wang Y, Wang L, Zhang H, Zhang H, Zhao B, Zhang A, Li Y.
Effects of nicotinamide on prevention and treatment of streptozotocin-induced
diabetes mellitus in rats.
Chin Med J (Engl). 1996 Nov;109(11):819-22.
PMID: 9275363
247: Greenbaum CJ, Kahn SE, Palmer JP.
Nicotinamide's effects on glucose metabolism in subjects at risk for IDDM.
Diabetes. 1996 Nov;45(11):1631-4.
PMID: 8866571
248: Elliott RB, Pilcher CC, Fergusson DM, Stewart AW.
A population based strategy to prevent insulin-dependent diabetes using
nicotinamide.
J Pediatr Endocrinol Metab. 1996 Sep-Oct;9(5):501-9.
PMID: 8961125
249: Jonas WB, Rapoza CP, Blair WF.
The effect of niacinamide on osteoarthritis: a pilot study.
Inflamm Res. 1996 Jul;45(7):330-4.
PMID: 8841834
250: Gale EA.
Theory and practice of nicotinamide trials in pre-type 1 diabetes.
J Pediatr Endocrinol Metab. 1996 May-Jun;9(3):375-9. Review.
PMID: 8887146
251: Rojas A, Vojnovic B, Johns H, Joiner MC, Martindale C, Fowler JF,
Denekamp
J.
Radiosensitisation in normal tissues with oxygen, carbogen or nicotinamide:
therapeutic gain comparisons for fractionated x-ray schedules.
Radiother Oncol. 1996 Apr;39(1):53-64.
PMID: 8735494
252: Velykyi MM, Burda VA, Biront NV, Oliiarnyk OD, Velykyi AM.
[The effect of nicotinamide on the enzymatic activity of the antioxidant
defense in experimental diabetes]
Ukr Biokhim Zh. 1996 Mar-Apr;68(2):109-14. Ukrainian.
PMID: 9005653
253: Stratford MR, Dennis MF, Hoskin PJ, Saunders MI, Hodgkiss RJ, Rojas
A.
Nicotinamide pharmacokinetics in normal volunteers and patients undergoing
palliative radiotherapy.
Acta Oncol. 1996;35(2):213-9.
PMID: 8639318
254: Gale EA.
Molecular mechanisms of beta-cell destruction in IDDM: the role of
nicotinamide.
Horm Res. 1996;45 Suppl 1:39-43. Review.
PMID: 8805029
255: Majamaa K, Rusanen H, Remes AM, Pyhtinen J, Hassinen IE.
Increase of blood NAD+ and attenuation of lactacidemia during nicotinamide
treatment of a patient with the MELAS syndrome.
Life Sci. 1996;58(8):691-9.
PMID: 8594319
256: Kosogorova LS, Kovalenko NN, Liubenko VA, Novosad FI.
[Recovery of immunological responsiveness in patients with bronchial asthma
during nicotinamide treatment]
Probl Tuberk. 1996;(5):41-4. Russian.
PMID: 8984491
257: Kaanders JH, Pop LA, Marres HA, van der Maazen RW, van der Kogel
AJ, van
Daal WA.
Radiotherapy with carbogen breathing and nicotinamide in head and neck
cancer:
feasibility and toxicity.
Radiother Oncol. 1995 Dec;37(3):190-8.
PMID: 8746587
258: Ohizumi Y, Lam GK, Pickles T, Fryer C, Chaplin DJ.
Radiosensitizing effect of nicotinamide and carbogen combined in fractionated
pions or x-rays in SCCVII tumors.
Radiat Med. 1995 Nov-Dec;13(6):291-5.
PMID: 8850370
259: Gruet P, Gaillard C, Boisrame B, Duffaut D, Grimoud AM, Camy G.
Use of an oral antiseptic bioadhesive tablet in dogs.
J Vet Dent. 1995 Sep;12(3):87-91.
PMID: 9693631
260: Ueki M, Yasunami Y, Motoyama K, Funakoshi A, Ikeda S, Tanaka M.
The amelioration of hyperglycemia in streptozotocin-induced diabetic rats
after
the intraportal transplantation of an insufficient number of islets by
nicotinamide treatment.
Transplantation. 1995 Aug 27;60(4):313-7.
PMID: 7652756
261: Kolbach DN, Remme JJ, Bos WH, Jonkman MF, De Jong MC, Pas HH, van
der Meer
JB.
Bullous pemphigoid successfully controlled by tetracycline and nicotinamide.
Br J Dermatol. 1995 Jul;133(1):88-90.
PMID: 7669647
262: Pozzilli P, Visalli N, Signore A, Baroni MG, Buzzetti R, Cavallo
MG,
Boccuni ML, Fava D, Gragnoli C, Andreani D, et al.
Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III
study).
Diabetologia. 1995 Jul;38(7):848-52.
PMID: 7556988
263: Shalita AR, Smith JG, Parish LC, Sofman MS, Chalker DK.
Topical nicotinamide compared with clindamycin gel in the treatment of
inflammatory acne vulgaris.
Int J Dermatol. 1995 Jun;34(6):434-7.
PMID: 7657446
264: Poskitt L, Wojnarowska F.
Treatment of cicatricial pemphigoid with tetracycline and nicotinamide.
Clin Exp Dermatol. 1995 May;20(3):258-9.
PMID: 7671428
265: Thomas CD, Prade M, Guichard M.
Tumour oxygenation, radiosensitivity, and necrosis before and/or after
nicotinamide, carbogen and perflubron emulsion administration.
Int J Radiat Biol. 1995 May;67(5):597-605.
PMID: 7775835
266: Behme MT.
Nicotinamide and diabetes prevention.
Nutr Rev. 1995 May;53(5):137-9. Review.
PMID: 7666987
267: Sawai T, Kitazawa K, Danno K, Sugie N, Machizuki T, Sugiura H, Uehara
M.
Pemphigus vegetans with oesophageal involvement: successful treatment
with
minocycline and nicotinamide.
Br J Dermatol. 1995 Apr;132(4):668-70.
PMID: 7748766
268: Pigott K, Dische S, Saunders MI.
Short communication: the addition of carbogen and nicotinamide to a palliative
fractionation schedule for locally advanced breast cancer.
Br J Radiol. 1995 Feb;68(806):215-8.
PMID: 7537598
269: Pozzilli P, Visalli N, Buzzetti R, Baroni MG, Boccuni ML, Fioriti
E,
Signore A, Mesturino C, Valente L, Cavallo MG, et al.
Adjuvant therapy in recent onset type 1 diabetes at diagnosis and insulin
requirement after 2 years.
Diabete Metab. 1995 Feb;21(1):47-9.
PMID: 7781843
270: Ueki M, Yasunami Y, Arima T, Motoyama K, Ikeda S, Tanaka M.
Protection of intrahepatic islet grafts from hyperglycemic toxicity by
nicotinamide treatment.
Transplant Proc. 1995 Feb;27(1):618.
PMID: 7879121
271: Horsman MR.
Nicotinamide and other benzamide analogs as agents for overcoming hypoxic
cell
radiation resistance in tumours. A review.
Acta Oncol. 1995;34(5):571-87. Review.
PMID: 7546822
272: Mallon E, Wojnarowska F.
Cicatricial pemphigoid presenting with unusual palmar involvement, successfully
treated with a combination of nicotinamide and tetracycline.
Clin Exp Dermatol. 1994 Nov;19(6):526-30.
PMID: 7889682
273: Fivenson DP, Breneman DL, Rosen GB, Hersh CS, Cardone S, Mutasim
D.
Nicotinamide and tetracycline therapy of bullous pemphigoid.
Arch Dermatol. 1994 Jun;130(6):753-8.
PMID: 8002646
274: Reimers JI, Andersen HU, Pociot F.
[Nicotinamide and prevention of insulin-dependent diabetes mellitus. Rationale,
effects, toxicology and clinical experiences. ENDIT Group]
Ugeskr Laeger. 1994 Jan 24;156(4):461-5. Review. Danish.
PMID: 8140661
275: Zackrisson B, Franzen L, Henriksson R, Littbrand B, Stratford M,
Dennis M,
Rojas AM, Denekamp J.
Acute effects of accelerated radiotherapy in combination with carbogen
breathing and nicotinamide (ARCON).
Acta Oncol. 1994;33(4):377-81.
PMID: 8018369
276: Horsman MR, Nordsmark M, Khalil AA, Hill SA, Chaplin DJ, Siemann
DW,
Overgaard J.
Reducing acute and chronic hypoxia in tumours by combining nicotinamide
with
carbogen breathing.
Acta Oncol. 1994;33(4):371-6.
PMID: 8018368
277: Rojas AM, Johns H, Fiat PR.
Should carbogen and nicotinamide be given throughout the full course of
fractionated radiotherapy regimens?
Int J Radiat Oncol Biol Phys. 1993 Dec 1;27(5):1101-5.
PMID: 8262834
278: Elliott RB, Pilcher CC, Stewart A, Fergusson D, McGregor MA.
The use of nicotinamide in the prevention of type 1 diabetes.
Ann N Y Acad Sci. 1993 Nov 30;696:333-41.
PMID: 8109840
279: Hiromatsu Y, Sato M, Tanaka K, Ishisaka N, Kamachi J, Nonaka K.
Inhibitory effects of nicotinamide on intercellular adhesion molecule-1
expression on cultured human thyroid cells.
Immunology. 1993 Oct;80(2):330-2.
PMID: 7903279
280: Chaplin DJ, Horsman MR, Siemann DW.
Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate
hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation
breathing time.
Br J Cancer. 1993 Aug;68(2):269-73.
PMID: 8347481
281: Ono K, Masunaga S, Akuta K, Akaboshi M, Abe M.
Radiosensitization of SCCVII tumours and normal tissues by nicotinamide
and
carbogen: analysis by micronucleus assay.
Radiother Oncol. 1993 Aug;28(2):162-7.
PMID: 8248558
282: Shishko PI, Sadykova RE, Shmagov AIu, Ragovin KE, Abugova IA, Shamkhalova
MSh.
[Role of nicotinamide in the onset and course of streptozotocin-induced
diabetes]
Probl Endokrinol (Mosk). 1993 May-Jun;39(3):38-40. Russian.
PMID: 8058679
283: Zemtsov A, Neldner KH.
Successful treatment of dermatitis herpetiformis with tetracycline and
nicotinamide in a patient unable to tolerate dapsone.
J Am Acad Dermatol. 1993 Mar;28(3):505-6.
PMID: 8445075
284: Alio JL, Ayala MJ, Mulet E, Artola A, Bellot JL, Ruiz-Moreno JM.
Treatment of experimental acute corneal inflammation with inhibitors of
the
oxidative metabolism.
Ophthalmic Res. 1993;25(5):331-6.
PMID: 8259267
285: Yourick JJ, Dawson JS, Mitcheltree LW.
Sulfur mustard-induced microvesication in hairless guinea pigs: effect
of
short-term niacinamide administration.
Toxicol Appl Pharmacol. 1992 Nov;117(1):104-9.
PMID: 1440603
286: White SD, Rosychuk RA, Reinke SI, Paradis M.
Use of tetracycline and niacinamide for treatment of autoimmune skin disease
in
31 dogs.
J Am Vet Med Assoc. 1992 May 15;200(10):1497-500.
PMID: 1535346
287: Peoples D, Fivenson DP.
Linear IgA bullous dermatosis: successful treatment with tetracycline
and
nicotinamide.
J Am Acad Dermatol. 1992 Mar;26(3 Pt 2):498-9.
PMID: 1532966
288: Manna R, Migliore A, Martin LS, Ferrara E, Ponte E, Marietti G,
Scuderi F,
Cristiano G, Ghirlanda G, Gambassi G.
Nicotinamide treatment in subjects at high risk of developing IDDM improves
insulin secretion.
Br J Clin Pract. 1992 Autumn;46(3):177-9.
PMID: 1286017
289: Michalkova D, Kolar J, Jancova E, Barak L, Silesova J.
[Early intensification of treatment in diabetes using a combination of
insulin
and nicotinamide--effect on C-peptide levels and the course of the disease]
Bratisl Lek Listy. 1992 Jan;93(1):11-5. Slovak.
PMID: 1388089
290: Lee I, Kim JH, Levitt SH, Song CW.
Increases in tumor response by pentoxifylline alone or in combination
with
nicotinamide.
Int J Radiat Oncol Biol Phys. 1992;22(3):425-9.
PMID: 1531211
291: Kjellen E, Joiner MC, Collier JM, Johns H, Rojas A.
A therapeutic benefit from combining normobaric carbogen or oxygen with
nicotinamide in fractionated X-ray treatments.
Radiother Oncol. 1991 Oct;22(2):81-91. Review.
PMID: 1835542
292: Elliott RB, Chase HP.
Prevention or delay of type 1 (insulin-dependent) diabetes mellitus in
children
using nicotinamide.
Diabetologia. 1991 May;34(5):362-5.
PMID: 1830860
293: Dzizinskii AA, Katiubin VP.
[Clinical course and necrotic area size in patients with myocardial infarct
receiving combined treatment including antioxidants and membrane-protecting
agents]
Kardiologiia. 1991 Apr;31(4):56-8. Russian.
PMID: 1829773
294: Shneider AB.
[Anti-ischemic heart protection using thiamine and nicotinamide]
Patol Fiziol Eksp Ter. 1991 Jan-Feb;(1):9-10. Russian.
PMID: 1829150
295: Horsman MR, Chaplin DJ, Overgaard J.
The use of blood flow modifiers to improve the treatment response of solid
tumors.
Radiother Oncol. 1991;20 Suppl 1:47-52. Review.
PMID: 1826963
296: Reddy S, Bibby NJ, Elliott RB.
Early nicotinamide treatment in the NOD mouse: effects on diabetes and
insulitis suppression and autoantibody levels.
Diabetes Res. 1990 Oct;15(2):95-102.
PMID: 2151892
297: Vialettes B, Picq R, du Rostu M, Charbonnel B, Rodier M, Mirouze
J, Vexiau
P, Passa P, Pehuet M, Elgrably F, et al.
A preliminary multicentre study of the treatment of recently diagnosed
type 1
diabetes by combination nicotinamide-cyclosporin therapy.
Diabet Med. 1990 Sep-Oct;7(8):731-5.
PMID: 2147636
298: Masiello P, Novelli M, Fierabracci V, Bergamini E.
Protection by 3-aminobenzamide and nicotinamide against streptozotocin-induced
beta-cell toxicity in vivo and in vitro.
Res Commun Chem Pathol Pharmacol. 1990 Jul;69(1):17-32.
PMID: 2145620
299: Ludwig A, Dietel M, Schafer G, Muller K, Hilz H.
Nicotinamide and nicotinamide analogues as antitumor promoters in mouse
skin.
Cancer Res. 1990 Apr 15;50(8):2470-5.
PMID: 2138506
300: Maurice DV, Jones JE, Lightsey SF, Rhoades JF.
Response of male poults to high levels of dietary niacinamide.
Poult Sci. 1990 Apr;69(4):661-8.
PMID: 2141405
301: Ovchinnikova NI.
[Rheopyrine and nicotinamide in the ambulatory treatment of acute
thrombophlebitis]
Vestn Khir Im I I Grek. 1989 Dec;144(12):48-51. Russian.
PMID: 2534725
302: Im MJ, Hoopes JE.
Improved skin flap survival with nicotinic acid and nicotinamide in rats.
J Surg Res. 1989 Nov;47(5):453-5.
PMID: 2530401
303: Smith YR, Klitzman B, Ellis MN, Kull FC Jr.
The effect of nicotinamide on microvascular density and thermal injury
in rats.
J Surg Res. 1989 Nov;47(5):465-9.
PMID: 2530402
304: Dzizinskii AA, Ana'nev AA, Fuks AR.
[Effect of membrane protectors on the diastolic function of the heart
in
patients with acute myocardial infarction]
Kardiologiia. 1989 Sep;29(9):52-5. Russian.
PMID: 2531814
305: Horsman MR, Chaplin DJ, Brown JM.
Tumor radiosensitization by nicotinamide: a result of improved perfusion
and
oxygenation.
Radiat Res. 1989 Apr;118(1):139-50.
PMID: 2523079
306: Mendola G, Casamitjana R, Gomis R.
Effect of nicotinamide therapy upon B-cell function in newly diagnosed
type 1
(insulin-dependent) diabetic patients.
Diabetologia. 1989 Mar;32(3):160-2.
PMID: 2526767
307: Shandra AA, Godlevskii LS, Mazarati AM, Makul'kin RF.
[Effect of delta sleep-inducing peptide, anticonvulsant preparations and
nicotinamide on generalized seizure activity]
Biull Eksp Biol Med. 1989 Feb;107(2):211-4. Russian.
PMID: 2522323
308: Horsman MR, Overgaard J, Christensen KL, Trotter MJ, Chaplin DJ.
Mechanism for the reduction of tumour hypoxia by nicotinamide and the
clinical
relevance for radiotherapy.
Biomed Biochim Acta. 1989;48(2-3):S251-4.
PMID: 2525032
309: Iakimova K, Micheva M, Bantutova I, Ovcharov R.
[Inhibition of morphine hyperthermia, induced by nicotinamide]
Eksp Med Morfol. 1989;28(1):33-7. Bulgarian.
PMID: 2526014
310: Nurmukhambetov AN, Riabtseva TA.
[Prevention of disorders of cardiac contractility with nicotinamide in
adriblastin -related damage]
Kardiologiia. 1988 Dec;28(12):91-3. Russian.
PMID: 2977417
311: Kjellen E, Pero RW, Nilsson P.
Comparison of low dose nicotinamide versus benzamide, administered per
os, as
radiosensitizers in a C3H mammary carcinoma.
Radiother Oncol. 1988 Aug;12(4):327-31.
PMID: 2973086
312: Handfield-Jones S, Jones S, Peachey R.
High dose nicotinamide in the treatment of necrobiosis lipoidica.
Br J Dermatol. 1988 May;118(5):693-6.
PMID: 2969260
313: Nikonova TV, Draudin-Krylenko VA, Bukin IuV, Turusov VS.
[Protective action of nicotinamide and pyridoxine on the initiation stage
of
carcinogenesis induced in mice by procarbazine]
Eksp Onkol. 1988;10(2):17-9. Russian.
PMID: 2968902
314: Vague P, Vialettes B, Lassmann-Vague V, Vallo JJ.
Nicotinamide may extend remission phase in insulin-dependent diabetes.
Lancet. 1987 Mar 14;1(8533):619-20.
PMID: 2881146
315: Obrosova IG, Efimov AS, Velikii NN, Avramenko NL, Zubkova ST.
[Hypoglycemic effect of nicotinamide in diabetes mellitus]
Farmakol Toksikol. 1987 Mar-Apr;50(2):113-5. Russian.
PMID: 2953627
316: Horsman MR, Brown DM, Lemmon MJ, Brown JM, Lee WW.
Preferential tumor radiosensitization by analogs of nicotinamide and benzamide.
Int J Radiat Oncol Biol Phys. 1986 Aug;12(8):1307-10.
PMID: 2944859
317: Neumann R, Rappold E, Pohl-Markl H.
Treatment of polymorphous light eruption with nicotinamide: a pilot study.
Br J Dermatol. 1986 Jul;115(1):77-80.
PMID: 2942169
318: Berk MA, Lorincz AL.
The treatment of bullous pemphigoid with tetracycline and niacinamide.
A
preliminary report.
Arch Dermatol. 1986 Jun;122(6):670-4.
PMID: 2940979
319: Grassetti DR.
The antimetastatic and tumor growth retarding effects of sulfur containing
analogs of nicotinamide.
Cancer Lett. 1986 May;31(2):187-95.
PMID: 2938726
320: Wahlberg G, Carlson LA, Wasserman J, Ljungqvist A.
Protective effect of nicotinamide against nephropathy in diabetic rats.
Diabetes Res. 1985 Nov;2(6):307-12.
PMID: 2934204
321: Kryzhanovskii GN, Shandra AA.
[Effect of diazepam and nicotinamide on convulsive activity of various
types]
Farmakol Toksikol. 1985 Jul-Aug;48(4):21-5. Russian.
PMID: 2931304
322: Blom W, van den Berg GB, Huijmans JG, Sanders-Woudstra JA.
Successful nicotinamide treatment in an autosomal dominant behavioral
and
psychiatric disorder.
J Inherit Metab Dis. 1985;8 Suppl 2:107-8.
PMID: 2931553
323: Render JA, Carlton WW.
Ocular lesions of 6-aminonicotinamide toxicosis in rabbits.
Vet Pathol. 1985 Jan;22(1):72-7.
PMID: 3156443
324: Gu CG, Chen WZ, Dong YL, Ding GS.
[Anti-arrhythmic effect of changrolin combined with nicotinamide in
experimental arrhythmia]
Zhongguo Yao Li Xue Bao. 1984 Sep;5(3):173-7. Chinese.
PMID: 6239508
325: Jonsson GG, Kjellen E, Pero RW.
Nicotinamide as a radiosensitizer of a C3H mouse mammary adenocarcinoma.
Radiother Oncol. 1984 Mar;1(4):349-53.
PMID: 6239306
326: Ma A, Medenica M.
Response of generalized granuloma annulare to high-dose niacinamide.
Arch Dermatol. 1983 Oct;119(10):836-9.
PMID: 6225398
327: Meerson FZ, Pshennikova MG, Rysmendiev AZh, Vorontsova EIa.
[Prevention of stress disorders of myocardial contractile function using
membrane protectors]
Kardiologiia. 1983 Jul;23(7):86-90. Russian.
PMID: 6225901
328: Varnakova GM.
[Use of nicotinamide for correcting the disordered nicotinic acid allowance
of
patients with noncoronarogenic heart diseases]
Vopr Pitan. 1983 Jul-Aug;(4):32-5. Russian.
PMID: 6226157
329: Bakai EA, Neschetnaia LB.
[Protective properties of nicotinamide and cytochrome C in aminoglycoside
ototoxicosis]
Fiziol Zh. 1983 Jan-Feb;29(1):68-73. Russian.
PMID: 6299811
330: Berger NA, Catino DM, Vietti TJ.
Synergistic antileukemic effect of 6-aminonicotinamide and
1,3-bis(2-chloroethyl)-1-nitrosourea on L1210 cells in vitro and in vivo.
Cancer Res. 1982 Nov;42(11):4382-6.
PMID: 6215118
331: Kryzhanovskii GN, Shandra AA, Godlevskii LS.
[Effect of nicotinamide on generalized convulsions in mice]
Farmakol Toksikol. 1982 Nov-Dec;45(6):13-7. Russian.
PMID: 6217985
332: Bourgeois BF, Dodson WE, Ferrendelli JA.
Interactions between primidone, carbamazepine, and nicotinamide.
Neurology. 1982 Oct;32(10):1122-26.
PMID: 6214728
333: Kryzhanovskii GN, Shandra AA, Godlevskii LS, Nikushkin EV.
[Effect of pantogam, nicotinamide, and phenazepam on seizure activity]
Biull Eksp Biol Med. 1982 Sep;94(9):61-4. Russian.
PMID: 6216928
334: Yamada K, Nonaka K, Hanafusa T, Miyazaki A, Toyoshima H, Tarui S.
Preventive and therapeutic effects of large-dose nicotinamide injections
on
diabetes associated with insulitis. An observation in nonobese diabetic
(NOD)
mice.
Diabetes. 1982 Sep;31(9):749-53.
PMID: 6219022
335: Braslavskii VE, Shchavelev VA, Kryzhanovskii GN, Nikushkin EV, Germanov
SB.
[Effect of nicotinamide on focal and generalized epileptic activity in
the
cerebral cortex]
Biull Eksp Biol Med. 1982 Aug;94(8):39-42. Russian.
PMID: 6215072
336: Vinogradov VV, Tarasov IuA, Vodoevich VP, Borets VM, Gal'tsev VA.
[Nicotinamide as an effective agent against endogenous hypocorticism during
prolonged corticosteroid therapy]
Vopr Pitan. 1981 Sep-Oct;(5):20-3. Russian.
PMID: 6274098
337: Kryzhanovskii GN, Shandra AA, Godlevskii LS, Beliaeva AI.
[Further study of the antiepileptic properties of nicotinamide]
Biull Eksp Biol Med. 1981;91(1):42-5. Russian.
PMID: 6452183
338: Sandor S, Checiu M, Fazakas-Todea I.
Regeneration of retinal pigment epithelium damaged in rat foetuses by
6-aminonicotinamide.
Morphol Embryol (Bucur). 1981 Jan-Mar;27(1):11-3.
PMID: 6454062
339: Pamukcu AM, Milli U, Bryan GT.
Protective effect of nicotinamide on bracken fern induced carcinogenicity
in
rats.
Nutr Cancer. 1981;3(2):86-93.
PMID: 6213941
340: Kryzhanovskii GN, Shandra AA.
[Use of nicotinamide and pyridoxal-5-phosphate to treat experimental epilepsy]
Zh Nevropatol Psikhiatr Im S S Korsakova. 1981;81(6):801-9. Russian.
PMID: 6457475
341: Kryzhanovskii GN, Shandra AA, Makul'kin RF, Lokasiuk BA, Godlevskii
LS.
[Effect of nicotinamide on epileptic activity in the cerebral cortex]
Biull Eksp Biol Med. 1980 JUL;89(7):37-41. Russian.
PMID: 6447523
342: Kohler IK, Lorincz AL.
Erythema elevatum diutinum treated with niacinamide and tetracycline.
Arch Dermatol. 1980 Jun;116(6):693-5.
PMID: 6445715
343: Chouinard G, Young SN, Annable L, Sourkes TL.
Tryptophan-nicotinamide, imipramine and their combination in depression.
A
controlled study.
Acta Psychiatr Scand. 1979 Apr;59(4):395-414.
PMID: 155389
344: Tischendorf L.
[Local nicotinamide therapy in erosive lichen of the oral mucosa]
Stomatol DDR. 1978 Dec;28(12):911-4. German.
PMID: 154199
345: Zackheim HS.
Topical 6-aminonicotinamide plus oral niacinamide therapy for psoriasis.
Arch Dermatol. 1978 Nov;114(11):1632-8.
PMID: 152612
346: Binnick SA.
Pityriasis rubra pilaris responding to aminonicotinamide.
Arch Dermatol. 1978 Sep;114(9):1348-9.
PMID: 150817
347: Kalich R, Gerloff W, Neubert R, Ulber H.
[Determination of the sensitivity of mycobacteria to pyrazinamide and
nicotinamide (author's transl)]
Z Erkr Atmungsorgane. 1978;151(2):103-12. German.
PMID: 153062
348: Otrokov AN.
[New methods of vitamin B treatment of itching dermatoses in middle aged
and
aged patients]
Vestn Dermatol Venerol. 1977 Dec;(12):62-5. Russian.
PMID: 146980
349: Masiello P, Bergamini E.
Nicotinamide and streptozotocin diabetes in the rat. Factors influencing
the
effectiveness of the protection.
Experientia. 1977 Sep 15;33(9):1246-7.
PMID: 142654
350: Comaish JS, Felix RH, McGrath H.
Topically applied niacinamide in isoniazid-induced pellagra.
Arch Dermatol. 1976 Jan;112(1):70-2.
PMID: 129035
351: Maitre M, Chesielski L, Lehmann A, Kempf E, Mandel P.
Protective effect of adenosine and nicotinamide against audiogenic seizure.
Biochem Pharmacol. 1974 Oct 15;23(20):2807-16.
PMID: 4154753
352: Bekier E, Wyczolkowska J, Szyc H, Maslinski C.
The inhibitory effect of nicotinamide on asthma-like symptoms and eosinophilia
in guinea pigs, anaphylactic mast cell degranulation in mice, and histamine
release from rat isolated peritoneal mast cells by compound 48-80.
Int Arch Allergy Appl Immunol. 1974;47(5):737-48.
PMID: 4139130
353: Fulton RL.
Prevention of endotoxic death with nicotinamide and adenosine triphosphate.
Surg Forum. 1974;25(0):17-9.
PMID: 4280146
354: Schein PS, Rakieten N, Cooney DA, Davis R, Vernon ML.
Streptozotocin diabetes in monkeys and dogs, and its prevention by
nicotinamide.
Proc Soc Exp Biol Med. 1973 Jun;143(2):514-8.
PMID: 4267772
355: Kintzel HW.
[Prevention of toxic hyperbilirubinemia in premature and mature newborn
infants
by use of an enzyme-inducing combination: phenobarbital-nikethamide]
Helv Paediatr Acta. 1973;30:Suppl:35-7. German.
PMID: 4711239
356: Carlson LA, Froberg S, Oro L.
A case of massive hypertriglyceridemia corrected by nicotinic acid or
nicotinamide therapy.
Atherosclerosis. 1972 Nov-Dec;16(3):359-68.
PMID: 4348602
357: Hinkel GK, Kintzel HW, Schwarze R, Handel A.
[Prevention of hyperbilirubinemia in premature infants using a combination
of
two enzyme inductors: phenobarbitol and nikethamide]
Dtsch Gesundheitsw. 1972 Sep 28;27(39):1854-7. German.
PMID: 4634399
358: Kintzel HW, Schwarze R, Hinkel GK.
[Prevention of transitory hyperbilirubinemia of the premature and mature
newborn infants and of the hemolytic disease of the newborn by an enzyme
induction combination: phenobarbital-nikethamide]
Schweiz Med Wochenschr. 1972 Sep 23;102(38):1339-45. German.
PMID: 4630163
359: Parkhomets PK, Kuchmerovskaia TM, Donchenko GV, Chichkovskaia GV,
Klimenko AP.
[Role of nicotinic acid and its derivatives in disorders of nervous system
function]
Ukr Biokhim Zh. 1995 Jul-Aug;67(4):3-11. Review. Russian.
PMID: 8553469
360: Graham AJ, Martin-Ruiz CM, Teaktong T, Ray MA, Court JA.
Human brain nicotinic receptors, their distribution and participation
in neuropsychiatric disorders.
Curr Drug Target CNS Neurol Disord. 2002 Aug;1(4):387-97. Review.
PMID: 12769611
361: Bencherif M, Schmitt JD.
Targeting neuronal nicotinic receptors: a path to new therapies.
Curr Drug Target CNS Neurol Disord. 2002 Aug;1(4):349-57. Review.
PMID: 12769609
362: Rusted JM, Newhouse PA, Levin ED.
Nicotinic treatment for degenerative neuropsychiatric disorders such as
Alzheimer's disease and Parkinson's disease.
Behav Brain Res. 2000 Aug;113(1-2):121-9. Review.
PMID: 10942039
363: Newhouse PA, Kelton M. Related Articles, Links
Nicotinic systems in central nervous systems disease: degenerative disorders
and beyond.
Pharm Acta Helv. 2000 Mar;74(2-3):91-101. Review.
PMID: 10812945
364: OSMOND H, HOFFER A. Related Articles, Links
Massive niacin treatment in schizophrenia. Review of a nine-year study.
Lancet. 1962 Feb 10;1:316-9.
PMID: 14482545
365: Resnik HL.
Suicide prevention and niacin.
JAMA. 1969 Jun 16;208(11):2164.
PMID: 5819000
366: Wittenborn JR.
A search for responders to niacin supplementation.
Arch Gen Psychiatry. 1974 Oct;31(4):547-52.
PMID: 4607587
367: Payne IR, Walsh EM, Whittenburg EJ.
Relationship of dietary tryptophan and niacin to tryptophan metabolism
in schizophrenics and nonschizophrenics.
Am J Clin Nutr. 1974 Jun;27(6):565-71.
PMID: 4830078
368: Wittenborn JR, Weber ES, Brown M.
Niacin in the long-term treatment of schizophrenia.
Arch Gen Psychiatry. 1973 Mar;28(3):308-15.
PMID: 4569673
369: Newbold HL, Mosher LR.
Niacin and the schizophrenic patient.
Am J Psychiatry. 1970 Oct;127(4):535-6.
PMID: 4248216
370: Hawkins DR, Bortin AW, Runyon RP.
Orthomolecular psychiatry: niacin and megavitamin therapy.
Psychosomatics. 1970 Sep-Oct;11(5):517-21.
PMID: 5470684
371: Ban TA.
On-going national collaborative studies in Canada: niacin
in the treatment of schizophrenias.
Psychopharmacol Bull. 1969 Jul;5(3):5-20. Review.
PMID: 4906584
372: Petrie WM, Ban TA, Ananth JV.
The use of nicotinic acid and pyridoxine in the treatment of schizophrenia.
Int Pharmacopsychiatry. 1981;16(4):245-50.
PMID: 7040274
|